Loading...
Aurora Cannabis Inc.
ACB.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$6.21
CA$0.010(0.16%)
Aurora Cannabis Inc. (ACB.TO) Financial Performance & Statements
Review Aurora Cannabis Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
15.86%
↑ 15.86%
Operating Income Growth
81.73%
↑ 81.73%
Net Income Growth
73.87%
↑ 73.87%
Operating Cash Flow Growth
40.85%
↑ 40.85%
Operating Margin
-10.96%
↓ 10.96%
Gross Margin
57.78%
↑ 57.78%
Net Profit Margin
-26.13%
↓ 26.13%
ROE
-6.40%
↓ 6.40%
ROIC
-2.02%
↓ 2.02%
Aurora Cannabis Inc. (ACB.TO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Aurora Cannabis Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $88.20M | $81.12M | $83.44M | $67.41M |
| Cost of Revenue | $9.20M | $38.96M | $38.89M | $16.24M |
| Gross Profit | $79.00M | $42.16M | $44.55M | $51.17M |
| Gross Profit Ratio | $0.90 | $0.52 | $0.53 | $0.76 |
| R&D Expenses | $929000.00 | $975000.00 | $987000.00 | $743000.00 |
| SG&A Expenses | $38.18M | $40.23M | $39.57M | $43.22M |
| Operating Expenses | $42.14M | $44.56M | $43.67M | $48.02M |
| Total Costs & Expenses | $51.34M | $83.51M | $82.56M | $64.26M |
| Interest Income | $2.60M | $2.97M | $3.35M | $2.89M |
| Interest Expense | $1.94M | $2.14M | $1.74M | $2.06M |
| Depreciation & Amortization | $5.43M | $5.42M | $5.74M | $6.89M |
| EBITDA | $39.44M | $8.16M | $15.18M | -$5.09M |
| EBITDA Ratio | $0.45 | $0.10 | $0.18 | -$0.08 |
| Operating Income | $36.86M | -$2.39M | $877000.00 | $3.15M |
| Operating Income Ratio | $0.42 | -$0.03 | $0.01 | $0.05 |
| Other Income/Expenses (Net) | -$4.79M | $3.00M | $6.82M | -$17.19M |
| Income Before Tax | $32.07M | $603000.00 | $7.70M | -$14.04M |
| Income Before Tax Ratio | $0.36 | $0.007 | $0.09 | -$0.21 |
| Income Tax Expense | $841000.00 | -$1.07M | $2.86M | -$711000.00 |
| Net Income | $31.67M | -$12.04M | $6.52M | -$17.41M |
| Net Income Ratio | $0.36 | -$0.15 | $0.08 | -$0.26 |
| EPS | $0.58 | -$0.22 | $0.13 | -$0.26 |
| Diluted EPS | $0.58 | -$0.22 | $0.13 | -$0.26 |
| Weighted Avg Shares Outstanding | $54.88M | $54.68M | $51.72M | $51.62M |
| Weighted Avg Shares Outstanding (Diluted) | $55.75M | $56.32M | $51.72M | $51.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan